Entries by Jennifer Huynh

New compound helps activate cancer-fighting T cells

April 2, 2018 in /by

Invariant natural killer T (iNKT) cells are powerful weapons our body’s immune systems count on to fight infection and combat diseases like cancer, multiple sclerosis, and lupus. Finding ways to spark these potent cells into action could lead to more effective cancer treatments and vaccines. While several chemical compounds have shown promise stimulating iNKT cells in […]

Jamie receives 2018 ASBMB Lemberg Medal

March 29, 2018 in /by

This prestigious medal honours Professor Rossjohn’s significant and sustained contributions to the understanding of the molecular basis underpinning immunity. Awarded annually, the Lemberg Medal is presented in memory of Emeritus Professor M.R. Lemberg, who was the Society’s first President and Honorary Member. Only three other scientists from Monash University have won this Medal. Professor Rossjohn […]

Could people living with coeliac disease one day be able to have their cake and eat it, too?

March 12, 2018 in /by

“If the stomach be irretentive of the food and if it pass through undigested and crude, and nothing ascends into the body, we call such persons coeliacs.” Although coeliac disease is fairly common, affecting about one in 70 people of European descent, it’s still challenging to diagnose and treat. It’s best known for its classic digestive symptoms – […]

Rheumatoid arthritis study rated among top by journal

February 28, 2018 in /by

A study by researchers in the Monash Biomedicine Discovery Institute’s (BDI) Infection and Immunity Program has shed light on the structures behind the genetic factor that predisposes people to getting the autoimmune disease rheumatoid arthritis (RA). The study by first author Dr Yi Tian Ting has been ranked an ‘Editors’ Pick’, among the top-rated papers […]

Monash extends collaboration with Janssen on psoriasis prevention

January 8, 2018 in /by

Monash University announced an extension of its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, where researchers will investigate triggers of the immune-mediated disease, psoriasis, and focus on the discovery of potential new treatment approaches to prevent psoriasis. Professor Jamie Rossjohn, from the Biomedicine Discovery Institute, Faculty of […]